Table 1 Baseline clinical characteristics of the entire cohort
Total n = 59 | ELCA group n = 21 | Non-ELCA group n = 38 | p value | |
|---|---|---|---|---|
Age (years) | 65.1 ± 10.1 | 65.5 ± 10.0 | 65.0 ± 10.3 | 0.850 |
Male sex (%) | 49 (83.1) | 17 (81.0) | 32 (84.2) | 0.733 |
Hypertension (%) | 40 (67.8) | 14 (66.7) | 26 (68.4) | 0.890 |
Hyperlipidemia (%) | 37 (62.7) | 14 (66.7) | 23 (60.5) | 0.641 |
Diabetes mellitus (%) | 29 (49.2) | 12 (57.1) | 17 (44.7) | 0.361 |
Previous MI (%) | 33 (56.3) | 11 (52.4) | 22 (57.9) | 0.683 |
Previous CVA (%) | 10 (16.9) | 6 (28.6) | 4 (10.5) | 0.144 |
Current smoker (%) | 34 (57.6) | 15 (71.4) | 19 (50.0) | 0.111 |
eGFR (mL/min/1.73 m2) | 90.6 ± 28.6 | 98.4 ± 26.3 | 88.5 ± 29.2 | 0.341 |
LVEF % | 59.5 (49.3, 60.0) | 49 (45, 63) | 60 (52, 60) | 0.627 |
LDL-C (mmol/L) | 2.03 ± 0.68 | 2.56 ± 1.00 | 1.97 ± 0.57 | 0.244 |
Clinical presentation | ||||
Stable angina (%) | 36 (61.0) | 14 (66.7) | 22 (57.9) | 0.508 |
ACS (%) | 23 (39.0) | 7 (33.3) | 16 (42.1) | 0.508 |